GSC-000829

N/A

Report date: 2025/02/12 14:53:44
NME

Base Information

Drug NameGSC-000829
Drug Alias NameGSC-000829GSC000829
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionFibroblast growth factor receptor 3 inhibitorsFibroblast growth factor receptor 2 inhibitors
TargetsFibroblast growth factor receptor 3Fibroblast growth factor receptor 2
Therapy Area/IndicationsAchondroplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChangchun GeneScience Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangchun GeneScience Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsAchondroplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A